{
    "id": "0659",
    "question": "A 64-year-old man with a history of type 2 diabetes mellitus is referred to a urologist. The patient has had pain when urinating and difficulty starting a stream of urine for over 4 months now. He is bothered because he has to urinate about 9 times every day, including several times when he wakes up at night. A digital rectal examination revealed multiple hard nodules in the prostate gland. A CT scan shows a nodule in the right lung that measures 3 cm. An ultrasound scan of his urinary bladder and prostate shows residual urine of > 200 mL and heterogeneous findings of the prostate gland. Biopsy reveals grade 2 prostate adenocarcinoma. Follow-up 9 months later shows his prostate cancer is well controlled with goserelin. If one considers pulmonary nodules that are the same size as this patient\u2019s, which of the following additional findings on CT scans would most likely prompt the removal of such nodules?",
    "options": {
        "A": "\u2018Popcorn\u2019 pattern",
        "B": "Subsolid component",
        "C": "Extending fine striations",
        "D": "Doubling time of < 1 month"
    },
    "answer": "C",
    "predict": "To approach this question, let's break down the key points and analyze the situation step by step: 1. **Patient's Condition**: The patient has a history of type 2 diabetes mellitus, symptoms of benign prostatic hyperplasia (BPH) such as nocturia (waking up multiple times at night to urinate) and difficulty starting urination, and a biopsy-confirmed grade 2 prostate adenocarcinoma. 2. **Current Treatment**: The patient is being treated with goserelin, a gonadotropin-releasing hormone (GnRH) agonist, which is typically used to treat prostate cancer by reducing testosterone levels, thereby slowing cancer growth. 3. **Question Focus**: We are looking for a characteristic on a CT scan of a pulmonary nodule (the same size as the patient's prostate nodule, 3 cm) that would prompt its removal. 4. **Options Analysis**: - **A. 'Popcorn' pattern**: This term refers to a pattern seen in CT scans where the nodule has a mixture of solid and cystic components. While this can be concerning, it's not the most definitive indicator for removal. - **B. Subsolid component**: The presence of a subsolid component within a nodule can be a marker of malignancy, as it indicates the presence of cancer cells within the nodule. This is a key concern for removal. - **C. Extending fine striations**: Fine striations can be seen in benign lesions but are also a feature of malignant lesions, particularly in adenocarcinomas. However, this finding alone might not be as definitive as a subsolid component for removal. - **D. Doubling time of < 1 month**: The doubling time of a nodule's size is an indicator of its growth rate. A doubling time of less than 1 month is concerning for malignancy, but it's not the most specific indicator for removal compared to the presence of a subsolid component. 5. **Conclusion**: Given the patient's history of prostate cancer and the fact that the question is asking about pulmonary nodules of the same size as his prostate nodule, the most concerning finding that would prompt removal of the pulmonary nodule is the presence of a subsolid component. This is because the subsolid component directly indicates the presence of cancer cells within the nodule, making it the most critical factor for removal. **Output:** ```json { \"step_by_step_thinking\": \"The key to answering this question lies in understanding the patient's history of prostate cancer and the characteristics of pulmonary nodules. The presence of a subsolid component in a pulmonary nodule is the most concerning feature for malignancy, especially in the context of a patient with a history of adenocarcinoma. This finding directly indicates the presence of cancer cells within the nodule, making it the most critical factor for removal.\", \"answer_choice\": \"B\" } ```",
    "snippets": [],
    "scores": [],
    "execution_time": 65.46335005760193
}